Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · IEX Real-Time Price · USD
3.600
-0.300 (-7.69%)
At close: May 1, 2024, 4:00 PM
3.800
+0.200 (5.56%)
After-hours: May 1, 2024, 6:18 PM EDT
HSDT Revenue
In the year 2023, Helius Medical Technologies had annual revenue of $644.00K, a decrease of -18.17%. Revenue in the quarter ending December 31, 2023 was $134.00K, a -52.48% decrease year-over-year.
Revenue (ttm)
$644.00K
Revenue Growth
-18.17%
P/S Ratio
4.96
Revenue / Employee
$29,273
Employees
22
Market Cap
3.19M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 644.00K | -143.00K | -18.17% |
| Dec 31, 2022 | 787.00K | 265.00K | 50.77% |
| Dec 31, 2021 | 522.00K | -139.00K | -21.03% |
| Dec 31, 2020 | 661.00K | -835.00K | -55.82% |
| Dec 31, 2019 | 1.50M | 1.02M | 212.97% |
| Dec 31, 2018 | 478.00K | - | - |
| Dec 31, 2017 | 0 | - | - |
| Mar 31, 2016 | 0 | - | - |
| Mar 31, 2015 | 0 | - | - |
| Mar 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| cbdMD | 23.45M |
| Applied DNA Sciences | 9.00M |
| Evoke Pharma | 5.18M |
| SciSparc | 2.88M |
| Aethlon Medical | 574.25K |
| Finch Therapeutics Group | 107.00K |
HSDT News
- 7 days ago - Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center - GlobeNewsWire
- 4 weeks ago - Helius Medical stock rallies 40%: explore why - Invezz
- 4 weeks ago - Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ - GlobeNewsWire
- 4 weeks ago - Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 weeks ago - Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 - GlobeNewsWire
- 7 weeks ago - Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke - GlobeNewsWire
- 7 weeks ago - Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference - GlobeNewsWire
- 2 months ago - Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller - GlobeNewsWire